Information entered must be in compliance with
OHRP (OIG Report notation) and
FDA (Recruiting Study Subjects
section) for clinical trial listings. The guidance limits information on web listings to:
title, purpose of the study, basic eligibility criteria; study site/location and how to
contact the study site for more information. Read the OHRP and FDA guidance before entering information.
Please answer all the questions below; all information is necessary for participation in the database. Incomplete submissions will NOT be posted.
Only one study per form; please complete a new form for
each additional study. Questions? Email clinicalstudies@uthscsa.edu.
PRINCIPAL INVESTIGATOR'S NAME: REQUIRED
CONTACT PERSON'S NAME: REQUIRED
Contact person's e-mail: REQUIRED
Contact person's phone: REQUIRED
Protocol Owner (enter University or University-related Department, Center, Institute or
Program name of protocol owner):
Clinical trial/study website address: (if applicable)
Title of trial/study: REQUIRED
(This does not need to be the 'formal' or official title of the study.)
IRB # (format: HSC-XXXX-XXXX): REQUIRED
Funding source:
Type of research/study: (select all that apply):
Healthy volunteers sought: REQUIRED Yes No
Conditions, diseases or illnesses being studied: REQUIRED
Purpose of Study: REQUIRED
Give only basic information concerning the purpose of the study by explaining what you are trying
to learn by doing this study. Do not state your expectations or hopes that participants may benefit by their participation. Include only the basic requirements (e.g. age group, non-smoker, and diabetic).
Do not include the investigator's qualifications. Do not include any form of compensation information such as monetary incentives, "free" exams, "free" medications/treatments, etc. Do not include any anticipated results. See OHRP and FDA links above. (Limit: 250 characters)
Start date of trial/study: REQUIRED
Trial/Study is ongoing (no ending date) Yes No
If you answered NO, trial is not ongoing, you must provide end date of trial:
Investigator's Department and Address: